Clinical Study

Nrg-Lu002- Maintenance Systemic Therapy Versus Consolidative Sterotactic Body Radiation Therapy (Sbrt) Plus Maintenance Systemic Therapy For Limited Metastatic Non-Small Cell Lung Cancer (Nsclc): A Randomized Phase II/III Trial

Posted Date: Jun 17, 2019

  • Investigator: Emily Daugherty
  • Specialties: Cancer, Lung Cancer, Oncology, Radiation Oncology
  • Type of Study: Drug

To goal of this study is to evaluate the impact of adding LCT (local consolidative therapy) to maintenance systemic therapy versus maintenance systemic therapy alone on progression-free survival for patients with metastatic NSCLC with no evidence of progression and limited metastatic sites after first-line systemic therapy

Criteria:

To Be Eligible: Diagnosed With Nsclc, Age 18 Or Older, Nonpregnant And Nonbreastfeeding, No Prior Invasive Malignancy In Last Year

Keywords:

Lung Cancer, Metastatic, Radiation Therapy

For More Information:

Uc Cancer Institute
513-584-7698
cancer@uchealth.com


  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at ResearchStudies@UCHealth.com or (513) 245-3417.